CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free QPT Stock Alerts C$0.02 -0.01 (-33.33%) (As of 05/31/2024 05:24 PM ET) Add Compare Share Share Today's RangeC$0.02▼C$0.0350-Day RangeC$0.02▼C$0.0452-Week RangeC$0.02▼C$0.11Volume182,000 shsAverage Volume50,625 shsMarket CapitalizationC$3.38 millionP/E RatioN/ADividend Yield6.15%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades Get Quest PharmaTech alerts: Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About Quest PharmaTech Stock (CVE:QPT)Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.Read More QPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QPT Stock News HeadlinesJune 2 at 5:54 AM | americanbankingnews.comQuest PharmaTech (CVE:QPT) Hits New 12-Month Low at $0.02May 26, 2024 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Wednesday (QPT)May 16, 2024 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Wednesday (QPT)February 20, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (QPT)February 20, 2024 | theglobeandmail.comPsyBio Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (PSYB)February 19, 2024 | theglobeandmail.comMarvel Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (MRVL)February 6, 2024 | finance.yahoo.comQuest PharmaTech Inc. (QPT.V)January 30, 2024 | ca.finance.yahoo.comQuest Receives Cash Dividend Payment from OncoQuestJanuary 21, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Biotechnology Industry Stocks (QPT)January 2, 2024 | cnet.comBest Meta Quest 2 Accessories for 2024November 6, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Thursday (QPT)October 14, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Thursday (QPT)September 29, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Tuesday (QPT)September 16, 2023 | time.comMeta Quest Promo CodesAugust 24, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Tuesday (QPT)August 17, 2023 | ca.finance.yahoo.comQPT.V - Quest PharmaTech Inc.August 5, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Monday (QPT)July 10, 2023 | finance.yahoo.comQuest PharmaTech Provides Product Development UpdateJune 7, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - QPTJune 6, 2023 | finance.yahoo.comQuest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.June 6, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - QPTMay 13, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Thursday (QPT)May 4, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Tuesday (QPT)April 27, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Wednesday (QPT)April 22, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Friday (QPT)See More Headlines Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/02/2024Next Earnings (Estimated)7/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CUSIPN/A CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-22,260,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.86% Return on Assets-0.94% Debt Debt-to-Equity Ratio1.51 Current Ratio0.26 Quick Ratio0.52 Sales & Book Value Annual SalesC$38,871.00 Price / Sales87.02 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.39 per share Price / Book0.05Miscellaneous Outstanding Shares169,130,000Free FloatN/AMarket CapC$3.38 million OptionableNot Optionable Beta0.25 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Ragupathy Madiyalakan Ph.D.CEO & DirectorMr. Pierre Vermette C.A.CPA, Chief Financial OfficerMr. Roger AndrewsHead of Investor Relations & Corporate CommunicationsMr. Douglas C. Bachman (Age 70)Vice President of Corporate Development Comp: $37.94kMr. Thomas WooVice President of Product DevelopmentKey CompetitorsReunion NeuroscienceTSE:REUNKane BiotechCVE:KNENeptune Wellness SolutionsTSE:NEPTAntibe TherapeuticsTSE:ATESirona BiochemCVE:SBMView All CompetitorsInsidersRagupathy MadiyalakanBought 15,290 shares on 9/15/2023Total: C$1,070.30 ($0.07/share)Ragupathy MadiyalakanBought 30,000 shares on 8/29/2023Total: C$2,100.00 ($0.07/share)Ragupathy MadiyalakanBought 20,000 shares on 8/25/2023Total: C$1,400.00 ($0.07/share)View All Insider Transactions QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed in 2024? Quest PharmaTech's stock was trading at C$0.06 on January 1st, 2024. Since then, QPT shares have decreased by 63.6% and is now trading at C$0.02. View the best growth stocks for 2024 here. When is Quest PharmaTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024. View our QPT earnings forecast. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Indiva (NDVA), CME Group (CME) and How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:QPT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.